GILD
Gilead Sciences, Inc.
Stock
$149.05−2.23 (−1.47%)Close Sep 30, 2026
| Net income (TTM) | 5-year CAGR | 10-year CAGR |
|---|---|---|
| −$3.2B | 133.3% | −7.3% |
| Net income (TTM) | −$3.2B |
|---|---|
| 5-year CAGR | 133.3% |
| 10-year CAGR | −7.3% |
Net income
| Period | Net income | YoY |
|---|---|---|
| 2025 | $8.5B | +1,672.9% |
| 2024 | $480M | −91.5% |
| 2023 | $5.7B | +23.4% |
| 2022 | $4.6B | −26.2% |
| 2021 | $6.2B | +4,961.0% |
| 2020 | $123M | −97.7% |
| 2019 | $5.4B | −1.3% |
| 2018 | $5.5B | +17.9% |
| 2017 | $4.6B | −65.7% |
| 2016 | $13.5B | −25.4% |
| 2015 | $18.1B | +49.6% |
| 2014 | $12.1B | +293.5% |
| 2013 | $3.1B | +18.6% |
| 2012 | $2.6B | −7.5% |
| 2011 | $2.8B | −3.4% |
| 2010 | $2.9B | +10.1% |
| 2009 | $2.6B | +33.2% |
| 2008 | $2.0B | +24.9% |
| 2007 | $1.6B | — |